Anemia in inflammatory bowel disease outpatients: Prevalence, risk factors, and etiology

BioMed Research International

Volumn 2015, Issue , 2015, Pages

  Antunes, Carla Valéria De Alvarenga ^a   Hallack Neto, Abrahão Elias ^a   Nascimento, Cristiano Rodrigo De Alvarenga ^a   Chebli, Liliana Andrade ^a   Moutinho, Ivana Lúcia Damásio ^a   Pinheiro, Bruno Do Valle ^a   Reboredo, Maycon Moura ^a   Malaguti, Carla ^a   Castro, Antonio Carlos Santana ^a   Chebli, Júlio Maria Fonseca ^a  

^a FEDERAL UNIVERSITY OF JUIZ DE FORA   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; CYANOCOBALAMIN; FERRITIN; FOLIC ACID; TRANSFERRIN;

ADULT; ANEMIA; ARTICLE; BLOOD CELL COUNT; BRAZILIAN; COHORT ANALYSIS; CROHN DISEASE; CROSS-SECTIONAL STUDY; DISEASE ACTIVITY; DISEASE ASSOCIATION; FEMALE; FOLIC ACID BLOOD LEVEL; HUMAN; IRON DEFICIENCY ANEMIA; MAJOR CLINICAL STUDY; MALE; OUTPATIENT; PREVALENCE; PROTEIN BLOOD LEVEL; RETICULOCYTE COUNT; RISK FACTOR; ULCERATIVE COLITIS; VITAMIN BLOOD LEVEL; ADOLESCENT; AGED; BLOOD; BRAZIL; COMPLICATION; INFLAMMATORY BOWEL DISEASES; METABOLISM; MIDDLE AGED; PATHOLOGY;

ADOLESCENT; ADULT; AGED; ANEMIA; BLOOD CELL COUNT; BRAZIL; C-REACTIVE PROTEIN; FEMALE; FERRITINS; FOLIC ACID; HUMANS; INFLAMMATORY BOWEL DISEASES; MALE; MIDDLE AGED; OUTPATIENTS; RISK FACTORS; TRANSFERRIN; VITAMIN B 12;

EID: 84924153825     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2015/728925     Document Type: Article

References (26)

1. S. Kulnigg and C. Gasche, "Systematic review: managing anaemia in Crohn's disease," Alimentary Pharmacology and Therapeutics, vol. 24, no. 11-12, pp. 1507-1523, 2006.
2. G. S. de Souza, F. M. Vidigal, L. A. Chebli et al., "Effect of azathioprine or mesalazine therapy on incidence of re-hospitalization in sub-occlusive ileocecal Crohn's disease patients," Medical Science Monitor, vol. 19, no. 1, pp. 716-722, 2013.
3. C. Gasche, "Anemia in IBD: the overlooked villain," Inflammatory Bowel Diseases, vol. 6, no. 2, pp. 142-150, 2000.
4. M. L. Hoivik, W. Reinisch, M. Cvancarova, and B. Moum, "Anaemia in inflammatory bowel disease: a population-based 10-year follow-up," Alimentary Pharmacology andTherapeutics, vol. 39, no. 1, pp. 69-76, 2014.
5. D. Guagnozzi and A. J. Lucendo, "Anemia in inflammatory bowel disease: a neglected issue with relevant effects," World Journal of Gastroenterology, vol. 20, no. 13, pp. 3542-3551, 2014.
6. C. Gasche, A. Berstad, R. Befrits et al., "Guidelines on the diagnosis and management of iron deficiency and anemia in inflammatory bowel diseases," Inflammatory Bowel Diseases, vol. 13, no. 12, pp. 1545-1553, 2007.
7. C. W. Wells, S. Lewis, J. R. Barton, and S. Corbett, "Effects of changes in hemoglobin level on quality of life and cognitive function in inflammatory bowel disease patients," Inflammatory Bowel Diseases, vol. 12, no. 2, pp. 123-130, 2006.
8. J. P. Gisbert, F. Bermejo, R. Pajares et al., "Oral and intravenous iron treatment in inflammatory bowel disease: hematological response and quality of life improvement," Inflammatory Bowel Diseases, vol. 15, no. 10, pp. 1485-1491, 2009.
9. K. Liu and A. J. Kaffes, "Iron deficiency anaemia: a review of diagnosis, investigation and management," European Journal of Gastroenterology and Hepatology, vol. 24, no. 2, pp. 109-116, 2012.
10. R. Befrits, O. Wikman, L. Blomquist et al., "Anemia and iron deficiency in inflammatory bowel disease: an open, prospective, observational study on diagnosis, treatment with ferric carboxymaltose and quality of life," Scandinavian Journal of Gastroenterology, vol. 48, no. 9, pp. 1027-1032, 2013.
11. F.Gomolĺon and J. P.Gisbert, "Anemia and inflammatory bowel diseases," World Journal of Gastroenterology, vol. 15, no. 37, pp. 4659-4665, 2009.
12. A. Wilson, E. Reyes, and J. Ofman, "Prevalence and outcomes of anemia in inflammatory bowel disease: a systematic review of the literature," The American Journal of Medicine, vol. 116, supplement 1, no. 7, pp. 44-49, 2004.
13. G. Bergamaschi, A. di Sabatino, R. Albertini et al., "Prevalence and pathogenesis of anemia in inflammatory bowel disease. Influence of anti-tumor necrosis factor-treatment," Haematologica, vol. 95, no. 2, pp. 199-205, 2010.
14. C. Ott and J. Scholmerich, "Extraintestinal manifestations and complications in IBD," Nature Reviews Gastroenterology and Hepatology, vol. 10, no. 10, pp. 585-595, 2013.
15. M. S. Silverberg, J. Satsangi, T. Ahmad et al., "Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a Working Party of the 2005 Montreal World Congress of Gastroenterology," The Canadian Journal ofGastroenterology, vol. 19,pp. 5A-36A, 2005.
16. S. C. Truelove and L. J. Witts, "Cortisone in ulcerative colitis; final report on a therapeutic trial," British Medical Journal, vol. 2, no. 4947, pp. 1041-1048, 1955.
17. World Health Organization, "Iron deficiency anemia assessment, prevention and control. A guide for programme managers," Report WHO/NHP/01.3, World Health Organization, Geneva, Switzerland, 2011.
18. N. Filmann, J. Rey, S. Schneeweiss et al., "Prevalence of anemia in inflammatory bowel diseases in European countries: a systematic review and individual patient data meta-analysis," Inflammatory Bowel Diseases, vol. 20, no. 5, pp. 936-945, 2014.
19. P. Bager, R. Befrits, O. Wikman et al., "The prevalence of anemia and iron deficiency in IBD outpatients in Scandinavia," Scandinavian Journal ofGastroenterology, vol. 46,no. 3, pp. 304-309, 2011.
20. J. P. Gisbert and F. Gomolĺon, "Common misconceptions in the diagnosis and management of anemia in inflammatory bowel disease,"The American Journal of Gastroenterology, vol. 103, no. 5, pp. 1299-1307, 2008.
21. R. A. Alves, S. J. Miszputen, and M. S. Figueiredo, "Anemia in inflammatory bowel disease: prevalence, differential diagnosis and association with clinical and laboratory variables," Sao Paulo Medical Journal, vol. 132, no. 3, pp. 140-146, 2014.
22. S. Schreiber, S. Howaldt, M. Schnoor et al., "Recombinant erythropoietin for the treatment of anemia in inflammatory bowel disease," The New England Journal of Medicine, vol. 334, no. 10, pp. 619-623, 1996.
23. E. Nemeth, S. Rivera, V. Gabayan et al., "IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin," The Journal of Clinical Investigation, vol. 113, no. 9, pp. 1271-1276, 2004.
24. W. Jelkmann, "Proinflammatory cytokines lowering erythropoietin production," Journal of Interferon and Cytokine Research, vol. 18, no. 8, pp. 555-559, 1998.
25. J. D. Lewis, "The utility of biomarkers in the diagnosis and therapy of inflammatory bowel disease," Gastroenterology, vol. 140, no. 6, pp. 1817-1826, 2011.
26. J. A. Leifert, "Anaemia and cigarette smoking," International Journal of Laboratory Hematology, vol. 30, no. 3, pp. 177-184, 2008.